Stay updated on Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Sign up to get notified when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.
Latest updates to the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedLocations sections were consolidated from individual state subsections (e.g., Alabama Locations) into a single combined Locations list covering multiple states. This update is labeled Revision: v3.3.3.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedFooter revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.0%
- Check54 days agoChange DetectedThe page no longer displays the general government funding/operating status notice. The study content and participation information remain unchanged.SummaryDifference0.3%
- Check68 days agoChange DetectedNo additions or deletions were detected between the screenshots; the page content and layout appear unchanged.SummaryDifference0.4%
- Check97 days agoChange DetectedCore content updated with a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference3%
- Check105 days agoChange DetectedUpdated to Revision: v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while keeping the revision label as the primary addition.SummaryDifference0.4%
Stay in the know with updates to Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.